Clinical biological Labs
Evaluate the Fluctuation in the Level of PTH, and Assess the Relationship Between PTH and Some Biochemical Parameter in Chronic Kidney Disease Patients Undergoing Hemodialysis

Zahraa H. Alsarraf; Nahla A. Saber

Volume 21, Issue 1 , March 2024, , Page 15-19

https://doi.org/10.33899/iraqij.p.2024.145254.1076

Abstract
  Background: As a key regulator of bone metabolism, parathyroid hormone (PTH) also modulates the homeostatic response to changes in plasma calcium concentrations. PTH values are often used in patients with “chronic kidney disease (CKD)” as a surrogate for assessing bone and mineral disease ...  Read More ...

The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City

Mohammed Khalid J. Al-Nori; Akram J. Ahmed

Volume 14, Issue 1 , June 2014, , Page 76-78

https://doi.org/10.33899/iphr.2019.161197

Abstract
  Background: Diagnostic marker to detect chronic kidney disease (CKD) at early stages is important as early intervention can slow the loss of kidney functions. Serum cystatin C (sCysC) is said to be a superior marker for CKD compared to serum creatinine (sCr) and other known markers in the near past ...  Read More ...